These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33005611)

  • 21. MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms.
    Morales-Burgos A; Sánchez JL; Figueroa LD; De Jesús-Monge WE; Cruz-Correa MR; González-Keelan C; Nazario CM
    P R Health Sci J; 2008 Dec; 27(4):322-7. PubMed ID: 19069357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sebaceous carcinoma: controversies and their evidence for clinical practice.
    Kibbi N; Worley B; Owen JL; Kelm RC; Bichakjian CK; Chandra S; Demirci H; Kim J; Nehal KS; Thomas JR; Poon E; Alam M
    Arch Dermatol Res; 2020 Jan; 312(1):25-31. PubMed ID: 31471636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].
    Kacerovská D; Kazakov DV; Cerná K; Hadravský L; Michal M; Dostál J; Skálová A; Michal M
    Cesk Patol; 2010 Oct; 46(4):86-94. PubMed ID: 21313735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.
    Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA
    Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Intrapatient Concordance Study of Mismatch Repair Protein Immunohistochemical Staining Patterns in Patients With Muir-Torre Syndrome.
    Nguyen CV; Gaddis KJ; Stephens MR; Seykora JT; Chu EY
    JAMA Dermatol; 2020 Jun; 156(6):676-680. PubMed ID: 32267475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clinicopathologic features, survival, and demographics in sebaceous carcinoma patients with and without Muir-Torre syndrome.
    Maloney NJ; Zacher NC; Hirotsu KE; Rajan N; Aasi SZ; Kibbi N
    J Am Acad Dermatol; 2023 Aug; 89(2):269-273. PubMed ID: 37003478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sebaceous adenomas of the eyelid and Muir-Torre Syndrome.
    Jagan L; Zoroquiain P; Bravo-Filho V; Logan P; Qutub M; Burnier MN
    Br J Ophthalmol; 2015 Jul; 99(7):909-13. PubMed ID: 25595178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients.
    Goldberg M; Rummelt C; Foja S; Holbach LM; Ballhausen WG
    Hum Mutat; 2006 Feb; 27(2):155-62. PubMed ID: 16395674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of mismatch repair proteins in sebaceous gland tumors.
    Popnikolov NK; Gatalica Z; Colome-Grimmer MI; Sánchez RL
    J Cutan Pathol; 2003 Mar; 30(3):178-84. PubMed ID: 12641777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature.
    Akhtar S; Oza KK; Khan SA; Wright J
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):681-6. PubMed ID: 10534628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
    Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
    Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.
    Tomonari M; Shimada M; Nakada Y; Yamamoto I; Itoh M; Koike Y; Kobayashi A; Miki J; Yamada H; Kimura T; Saito S; Sugano K; Sekine S; Yamamoto H; Asahina A; Yokoo T
    BMC Nephrol; 2019 Oct; 20(1):394. PubMed ID: 31664942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sebaceous tumors of the eyelids in a patient with Muir-Torre syndrome].
    Bertholom JL; Guyomard JL; Stock N; Dugast C; Martinel C; Chatel MA; Charlin JF
    J Fr Ophtalmol; 2006 Jun; 29(6):654-8. PubMed ID: 16885896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muir-Torre syndrome in a haemodialysis patient.
    Godfrey ED; Coward RA; Gharpuray-Pandit D; Lalloo F; McKirdy S; Woywodt A
    Clin Kidney J; 2013 Aug; 6(4):414-7. PubMed ID: 27293570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
    Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R
    Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular Adnexal Adenomatoid Sebaceous Gland Hyperplasia: A Clinical and Immunopathologic Analysis in Relation to the Muir-Torre Syndrome.
    Jakobiec FA; Cortes Barrantes P; Milman T; Lee NG; Fay A
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):e6-e12. PubMed ID: 31593035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muir-Torre syndrome: case report and review of the literature.
    Ang JM; Alai NN; Ritter KR; Machtinger LA
    Cutis; 2011 Mar; 87(3):125-8. PubMed ID: 21488569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reticulated acanthoma with sebaceous differentiation: another sebaceous neoplasm associated with Muir-Torre syndrome?
    Shon W; Wolz MM; Newman CC; Bridges AG
    Australas J Dermatol; 2014 Nov; 55(4):e71-3. PubMed ID: 23651324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.